Pharmaceutical Services Negotiating Committee (PSNC) - News updates


PQS: Reminder – Two weeks left to claim your Aspiration payment

Community pharmacy contractors have two weeks left to claim their Aspiration payment for the Pharmacy Quality Scheme (PQS) as the window for claiming this payment closes on Friday 1st November at 11.59pm. Contractors are required to claim their Aspiration payment via the NHS Business Services Authority’s (NHSBSA) Manage Your Service (MYS) application. Contractors are only eligible for...

Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg and 300mg

Class 2 MHRA medicines recall – Ranitidine Effervescent Tablets 150mg and 300mg (Teva UK Limited trading as ratiopharm GmbH) Drug alert number: EL (19)A/27 Date issued: 17 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Ranitidine Effervescent Tablets 150mg and 300mg (Teva UK Limited trading...

Further medicines added to the list of medicines that cannot be parallel exported from the UK

Further to our news story Temporary parallel export ban issued to ensure continued supply of medicines the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that a further four medicines are to be added to the list of medicines which must not be parallel exported...

PQS: Support available for the dementia-friendly environment checklist and action plan

Community pharmacy contractors may now like to consider completing the dementia-friendly environment checklist and action plan to meet the quality criterion, if they have not already done so. To meet the dementia-friendly environment checklist quality criterion, contractors are required to have completed, on the day of the declaration, a specified dementia-friendly environment checklist and have...

Class 4 MHRA drug alert – Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited)

Class 4 MHRA drug alert – Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited) Drug alert number: EL (19)A/26 Date issued: 16 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited) Alliance Pharmaceuticals...

PQS: Directory of Services (DoS) update

We have been made aware that, due to the NHS Urgent Medicine Supply Advanced Service (NUMSAS) and the Digital Minor Illness Referral Service (DMIRS) finishing on 28th October 2019 and the Community Pharmacist Consultation Service (CPCS) starting on 29th October 2019, that this has caused some confusion for community pharmacy contractors when updating their DoS...

Contractor Notice: Class 4 Drug Alert For Information / Action Rifadin (Rifampicin) 150mg Capsules

Class 4 MHRA drug alert – Rifadin (rifampicin) 150mg Capsules (Aventis Pharma Limited t/a Sanofi) Drug alert number: EL (19)A/25 Date issued: 16 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Rifadin (rifampicin) 150mg Capsules – PL 04425/5915R Aventis Pharma Limited t/a...

Supply Disruption Alert – Ranitidine all oral formulations

All oral formulations of Ranitidine are anticipated to be out of stock, with no date for resupply until further notice. The following oral presentations of Ranitidine are affected: Ranitidine 75mg, 150mg and 300mg tablets Ranitidine 150mg and 300mg effervescent tablets Ranitidine 150mg/5ml oral solution Ranitidine 75mg/5ml oral solution The Supply Disruption Alert (SDA/2019/005) issued by DHSC...

PSNC responds to government consultation on prevention

PSNC has outlined how community pharmacies can contribute to the prevention agenda in its response to a government consultation. Earlier this year, the Government set out a green paper, Advancing our health: prevention in the 2020s, outlining policy ideas to help prevent ill-health. The paper then opened to consultation in the form of an online...

Contractor Notice: SSP Endorsement Errors

Following the announcement of the first Serious Shortage Protocols (SSPs) issued on 3rd October 2019 for Fluoxetine capsules, PSNC has been working with NHS Business Services Authority (NHSBSA) to understand if claims are being submitted in accordance with SSP endorsement guidance. During the month of October, NHSBSA has received a number of EPS messages which...